A comprehensive view of Vaccination / Immunization. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Consumer Wellness Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

AstraZeneca to triple its R&D investment in China, hire over 900 R&D personnel in the country; AstraZeneca to offer at least 15 new drugs in Chinese market by 2030, including oncology, respiratory disease, immunization, vaccines, rare disease drugs
Published: March 27, 2023 by ForeignAffairs.co.nz
Moderna CEO defends company’s plans to hike cost of its COVID-19 vaccine from less than US$30 per dose to US$130 per dose later this year in Senate hearing; senators criticized the move, noting US invested nearly US$2.0B to develop the vaccine
Published: March 27, 2023 by Huntington Herald-Press (IN)
BioNTech Q4 profit down at €2.28B from €3.17B a year ago on weak revenues of €4.28B; sees FY23 COVID-19 vaccine revenues of €5.0B
Published: March 27, 2023 by CE Noticias Financieras (Latin America)
BioNTech Announces Fourth Quarter and Full Year 2022 Financial Results and Corporate Update
Published: March 27, 2023 by BioNTech SE
Moderna to host fourth annual Virtual Vaccines Day on April 11, 2023 at 8 a.m. ET for analysts and investors; Vaccines Day will include presentations from management and opinion leaders on Moderna's mRNA vaccines and considerations for vaccine development
Published: March 24, 2023 by Moderna Inc.

Ask us about our Consumer Wellness market view

Trending Chart

Interactive chart with headline count